193 related articles for article (PubMed ID: 27214396)
1. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
[TBL] [Abstract][Full Text] [Related]
4. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
[TBL] [Abstract][Full Text] [Related]
5. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC
Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort.
Silva PRS; Jannes CE; Oliveira TGM; Krieger JE; Santos RD; Pereira AC
J Clin Lipidol; 2022; 16(2):198-207. PubMed ID: 35181259
[TBL] [Abstract][Full Text] [Related]
8. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
9. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
10. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
[TBL] [Abstract][Full Text] [Related]
11. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study.
Sánchez-Ramos A; Fernández-Labandera C; Vallejo-Vaz AJ; Bonacho EC; Quevedo-Aguado L; Catalina-Romero C; Valdivielso P; Sánchez-Chaparro MÁ
Atherosclerosis; 2021 Dec; 338():39-45. PubMed ID: 34785430
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
15. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
18. No certain predictors for mutation status in a Danish cohort with familial hypercholesterolemia: a descriptive study.
Nybo M; Brusgaard K; Hansen AB
Clin Biochem; 2007 Dec; 40(18):1347-52. PubMed ID: 17961529
[TBL] [Abstract][Full Text] [Related]
19. Reverse Cascade Screening for Familial Hypercholesterolemia.
Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
